or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    CNTA D Centessa Pharmaceuticals plc -6.07
    ADCT C ADC Therapeutics SA -5.91
    RENB F Renovaro Biosciences Inc. -5.83
    ACLX F Arcellx, Inc. -5.67
    VINC F Vincera Pharma, Inc. -5.59
    CLLS B Cellectis S.A. -5.56
    ORIC F Oric Pharmaceuticals, Inc. -5.37
    ONCT D Oncternal Therapeutics, Inc. -5.28
    CLRB D Cellectar Biosciences, Inc. -5.25
    CRIS C Curis, Inc. -4.78
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Medicine Clinical Medicine Biopharmaceutical Biotechnology Drugs Multiple Myeloma Treatment Of Cancer Acute Myeloid Leukemia Advanced Solid Tumors Antibody Drug Conjugate Antineoplastic Drugs Blastoma Cancer Therapeutics Chemotherapy Glioblastoma Immunotherapy Leukemia Lung Cancer Lymphoma

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    PTH D Invesco DWA Healthcare Momentum ETF 2.96
    SBIO D ALPS Medical Breakthroughs ETF 2.78
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.78
    CNCR D Loncar Cancer Immunotherapy ETF 2.59
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.96
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare PTH to CNCR Compare PTH to LABD Compare SBIO to BBC

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 10 ACLX Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge
        May 10 CRIS Curis to Present Updated Data from the TakeAim Leukemia Study
        May 10 ACLX Arcellx GAAP EPS of -$0.14, revenue of $39.3M
        May 10 ACLX Kite and Arcellx prepare to launch Phase III multiple myeloma trial
        May 9 ONCT Oncternal Therapeutics, Inc. (ONCT) Q1 2024 Earnings Call Transcript
        May 9 ACLX Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset
        May 9 ACLX Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates
        May 9 ONCT Oncternal Therapeutics GAAP EPS of -$2.83 beats by $0.05, revenue of $0.57M beats by $0.44M
        May 9 ACLX Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 ACLX Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 ONCT Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
        May 9 ACLX Arcellx Provides First Quarter 2024 Financial Results
        May 8 ONCT Oncternal Therapeutics Q1 2024 Earnings Preview
        May 8 CRIS Curis, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call Transcript
        May 8 ORIC We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
        May 8 CLRB Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
        May 8 CRIS Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript
        May 7 ACLX Arcellx to Participate in Two Upcoming Investor Conferences
        May 7 CRIS Curis GAAP EPS of -$2.05, revenue of $2.1M
        May 7 CRIS Curis Provides First Quarter 2024 Business Update
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Medicine Cancer Biotechnology Drugs Clinical Medicine Immune System Monoclonal Antibodies Antibodies Cancer Immunotherapy Cancer Treatment Carcinoma Checkpoint Inhibitor Disease Hematological Cancers Immunology Immunotherapies Immunotherapy Lymphoma Multiple Myeloma Non Small Cell Lung Cancer
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags